BIOMAT Database Logo BIOMAT Database Logo

[Pathology of HTLV III/LAV virus infection]. 1986

L Vago, and C L Parravicini, and C M Antonacci, and S Cristina, and G C Costanzi, and A Lazzarin, and M Moroni, and E Berti, and L Nonnenmacher, and J C Gluckman

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency

Related Publications

L Vago, and C L Parravicini, and C M Antonacci, and S Cristina, and G C Costanzi, and A Lazzarin, and M Moroni, and E Berti, and L Nonnenmacher, and J C Gluckman
[Acute LAV/HTLV III infection].
January 1986, Nordisk medicin,
L Vago, and C L Parravicini, and C M Antonacci, and S Cristina, and G C Costanzi, and A Lazzarin, and M Moroni, and E Berti, and L Nonnenmacher, and J C Gluckman
Transmission of HTLV III/LAV infection.
October 1986, Indiana medicine : the journal of the Indiana State Medical Association,
L Vago, and C L Parravicini, and C M Antonacci, and S Cristina, and G C Costanzi, and A Lazzarin, and M Moroni, and E Berti, and L Nonnenmacher, and J C Gluckman
[HTLV III/LAV (AIDS)-infection protection].
July 1986, Quintessenz Journal,
L Vago, and C L Parravicini, and C M Antonacci, and S Cristina, and G C Costanzi, and A Lazzarin, and M Moroni, and E Berti, and L Nonnenmacher, and J C Gluckman
AIDS update: HTLV-III/LAV infection.
January 1986, Pennsylvania medicine,
L Vago, and C L Parravicini, and C M Antonacci, and S Cristina, and G C Costanzi, and A Lazzarin, and M Moroni, and E Berti, and L Nonnenmacher, and J C Gluckman
[Spontaneous course of LAV/HTLV-III infection].
October 1986, Deutsche medizinische Wochenschrift (1946),
L Vago, and C L Parravicini, and C M Antonacci, and S Cristina, and G C Costanzi, and A Lazzarin, and M Moroni, and E Berti, and L Nonnenmacher, and J C Gluckman
[Seborrheic dermatitis in HTLV-III/LAV infection].
January 1987, Medicina clinica,
L Vago, and C L Parravicini, and C M Antonacci, and S Cristina, and G C Costanzi, and A Lazzarin, and M Moroni, and E Berti, and L Nonnenmacher, and J C Gluckman
HTLV-III/LAV infection in hemodialysis patients.
May 1986, JAMA,
L Vago, and C L Parravicini, and C M Antonacci, and S Cristina, and G C Costanzi, and A Lazzarin, and M Moroni, and E Berti, and L Nonnenmacher, and J C Gluckman
LAV/HTLV-III infection in female prostitutes.
November 1985, Lancet (London, England),
L Vago, and C L Parravicini, and C M Antonacci, and S Cristina, and G C Costanzi, and A Lazzarin, and M Moroni, and E Berti, and L Nonnenmacher, and J C Gluckman
Ribavirin in HTLV-III/LAV infection of infants.
April 1986, Lancet (London, England),
L Vago, and C L Parravicini, and C M Antonacci, and S Cristina, and G C Costanzi, and A Lazzarin, and M Moroni, and E Berti, and L Nonnenmacher, and J C Gluckman
[Three names--one virus: HTLV-III/LAV/HIV].
August 1987, Die Quintessenz,
Copied contents to your clipboard!